Loading interactive chart...
1DInterval:
Date Range
1 min
DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.
Beyond analysts' top -and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.